Jonathan Rubin, SVP and Chief Medical Officer of Supernus, Inc., filed a Form 3 initial statement of beneficial ownership on November 4, 2026, disclosing no securities of the company held as of the date he became subject to reporting obligations.

Key Highlights

  • Reporting person: Jonathan Rubin, identified in the filing as SVP, Chief Medical Officer of Supernus, Inc. (NASDAQ:SUPN)
  • Event date: The date of the event requiring the statement is listed as November 2, 2026
  • No securities held: Both Table I (non-derivative securities) and Table II (derivative securities) are blank, with the filing stating no securities are beneficially owned
  • Filing remark: The filing states, "As of the time the Reporting Person became subject to beneficial ownership reporting obligations with respect to the Issuer, the Reporting Person did not beneficially own any securities of the Issuer"
  • Signed by attorney-in-fact: The form was signed by Timothy C. Dec as attorney-in-fact on November 4, 2026

Supernus CMO Jonathan Rubin Reports Zero Holdings at Onset of Reporting Obligations

Jonathan Rubin filed a Form 3 with the U.S. Securities and Exchange Commission on November 4, 2026, as required under Section 16(a) of the Securities Exchange Act of 1934. The filing covers Supernus, Inc., listed on NASDAQ under the symbol SUPN, and was submitted by one reporting person. The event triggering the filing is dated November 2, 2026, which the filing identifies as the date Rubin became subject to beneficial ownership reporting obligations.

According to the filing, Rubin holds the title of SVP, Chief Medical Officer at Supernus, Inc., with a listed address at 9715 Key West Avenue, Rockville, Maryland 20850. The filing explicitly notes that neither non-derivative nor derivative securities are reported in the ownership tables, and includes the remark that "the Reporting Person did not beneficially own any securities of the Issuer" as of the time he became subject to reporting requirements.

The form was executed by Timothy C. Dec, acting as attorney-in-fact under a referenced Power of Attorney (Exhibit 24), and was signed on November 4, 2026. No amendment date is listed, indicating this is an initial, not amended, statement.

What Was Disclosed

Supernus, Inc. officer Jonathan Rubin submitted an initial beneficial ownership statement reporting zero shares of company stock, both directly and indirectly, in non-derivative and derivative form, as of November 2, 2026.